India crosses 100 million-mark in conducting coronavirus tests: ICMR

India has crossed the 100 million-mark in conducting tests for the detection of Covid-19 as with an average testing of more than 1 million samples per day in the last 17 days, ICMR said

Topics
Coronavirus Vaccine | ICMR

Press Trust of India  |  New Delhi 

covid-19, vaccine, coronavirus
Representative image

India has crossed the 10 crore-mark in conducting tests for the detection of COVID-19as on Thursday with an average testing of more than 10 lakh samples per day in the last 17 days, the Indian Council of Medical Research (ICMR) said.

Till now, 74,000 tests per million population have been conducted.

India has conducted last 5 crore sample testing in only 45 days, LokeshSharma, scientist and media coordinator at said.

As on September 8, India had tested 5 crore COVID-19 samples, and in less than 50 days on October 22, it has reached the 10 crore-mark, Sharma said.

"This has been enabled by rapidly increasing testing infrastructure and capacity across the country. The has been enhancing COVID-19 testing capability across the country by expanding and diversifying testing capacity by leveraging technology and facilitating innovation in affordable diagnostic kits," the said in a statement.

Balram Bhargava, Director General, ICMR said, We have effectively responded to the evolving epidemic through focused and collaborative efforts of the Centre, state and UT governments."

"Exponential increase in testing has led to early identification, prompt isolation and effective treatment of COVID-19 cases along with effective contact tracing. These have eventually resulted in a sustained low fatality rate," he said.

"This testing milestone is testimony to the fact that India has been successful in implementing strategy of 5T approach 'Test, Track, Trace, Treat and use of Technology efficiently, which will enable us to contain the spread of the pandemic," he added.

Ramping up of testing facility across India was at the core of increased testing per day, he said.

Through our ardent efforts, it was ensured that a specific testing platform is made available addressing general testing (RT-PCR), High-throughput testing (COBAS), testing at remotest places and PHCs (TrueNAT, CBNAAT),in containment areas (rapid antigen testing) and for a large number and migrant population testing (pooled sample testing), Bhargava said.

The total number of diagnostic laboratory has reached 1,989. Of which dedicated government laboratories are 1,122and private laboratories number stands at 867.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus Vaccine
First Published: Fri, October 23 2020. 07:59 IST
RECOMMENDED FOR YOU